CYP2C19 genotype and adverse cardiovascular outcomes after stent implantation in clopidogrel-treated Asian populations: A systematic review and meta-analysis.

about

CYP2C19 genotype and adverse cardiovascular outcomes after stent implantation in clopidogrel-treated Asian populations: A systematic review and meta-analysis.

Item

http://www.wikidata.org/entity/Q47652515

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

CYP2C19 genotype and adverse c ...... atic review and meta-analysis.

@en

CYP2C19 genotype and adverse c ...... atic review and meta-analysis.

@nl

type

Item

label

CYP2C19 genotype and adverse c ...... atic review and meta-analysis.

@en

CYP2C19 genotype and adverse c ...... atic review and meta-analysis.

@nl

prefLabel

CYP2C19 genotype and adverse c ...... atic review and meta-analysis.

@en

CYP2C19 genotype and adverse c ...... atic review and meta-analysis.

@nl

P1476

CYP2C19 genotype and adverse c ...... atic review and meta-analysis.

@en

P2093

Fang Fang

http://www.w3.org/2001/XMLSchema#string

Jiayang Wang

http://www.w3.org/2001/XMLSchema#string

Jumana AlHelal

http://www.w3.org/2001/XMLSchema#string

Yujie Zhou

http://www.w3.org/2001/XMLSchema#string

Ziwei Xi

http://www.w3.org/2001/XMLSchema#string

P2860

Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses

Clinical significance of the cytochrome P450 2C19 genetic polymorphism

Ticagrelor versus clopidogrel in patients with acute coronary syndromes

High doses of clopidogrel to overcome genetic resistance: the randomized crossover CLOVIS-2 (Clopidogrel and Response Variability Investigation Study 2).

CYP2C19 phenotype, stent thrombosis, myocardial infarction, and mortality in patients with coronary stent placement in a Chinese population.

Cytochrome p-450 polymorphisms and response to clopidogrel.

Cytochrome P450 CYP 2C19*2 Associated with Adverse 1-Year Cardiovascular Events in Patients with Acute Coronary Syndrome.

Impact of CYP2C19 Variants on Clinical Efficacy of Clopidogrel and 1-Year Clinical Outcomes in Coronary Heart Patients Undergoing Percutaneous Coronary Intervention.

Limited frequency of the CYP2C19*17 allele and its minor role in a Japanese population

CYP2C19 loss-of-function alleles are not associated with clinical outcome of clopidogrel therapy in patients treated with newer-generation drug-eluting stents

P304

229-240

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

meta-analysis

P356

10.1080/09537104.2017.1413178

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Wei Liu

P577

2017-12-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29257922

http://www.w3.org/2001/XMLSchema#string

P921

clopidogrel